Key Details
Price
$87.50Last Dividend
$0.47PE Ratio
21.29Annual ROE
13.50%Beta
0.40Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 6, 2025Recent annual earnings:
May 14, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Sep 27, 2018Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
TARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2024.
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel.
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a portfolio mix of proteins, baked goods, and distribution, with 70% sales from foodservice and retail chains. The macro environment suggests lower interest rates, but inflation and wage increases could impact PBH's middle and low-income customer base.
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Anthony Lebiedzinski - Sidoti & Co. Operator Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
FAQ
- What is the ticker symbol for Prestige Consumer Healthcare?
- Does Prestige Consumer Healthcare pay dividends?
- What sector is Prestige Consumer Healthcare in?
- What industry is Prestige Consumer Healthcare in?
- What country is Prestige Consumer Healthcare based in?
- When did Prestige Consumer Healthcare go public?
- Is Prestige Consumer Healthcare in the S&P 500?
- Is Prestige Consumer Healthcare in the NASDAQ 100?
- Is Prestige Consumer Healthcare in the Dow Jones?
- When was Prestige Consumer Healthcare's last earnings report?
- When does Prestige Consumer Healthcare report earnings?
- Should I buy Prestige Consumer Healthcare stock now?